Singh et al. [10] reported that dipeptidyl peptidase IV (DPP-IV) cleaves incretin hormones such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), resulting in DM2. This evidence concerns the gene GIP and myotonic dystrophy type 2.